MHRA warns Ozempic/Wegovy could cause rare eye condition
TL;DR
Britain's MHRA has warned that the diabetes/weight‑loss injections Ozempic (semaglutide) and Wegovy may cause a rare optic nerve condition (NAION) that can lead to sudden vision loss in one eye. The regulator has received three reports, but says the overall risk is very small; with about two million UK users, patients and clinicians are advised to be alert to symptoms and seek urgent eye care if vision changes occur. The warning also notes that pancreatitis is a known but infrequent side effect of GLP-1 weight‑loss drugs.
- Ozempic and Wegovy could damage your eyesight, regulator warns The Times
- Fat jabs can cause vision loss, regulator warns The Telegraph
- Small risk of severe acute pancreatitis with weight-loss jabs, UK regulator warns The Guardian
- Doctors warn Ozempic can cause 'eye strokes' and BLINDNESS in fresh warning over weight loss injections dailymail.co.uk
- GLP-1 Warning Over Link to Fatal Events; DOJ Sues Med School; Genes and Longevity MedPage Today
Want the full story? Read the original reporting
Read on The Times